Pre-clinical animal research must improve

Less than five percent of promising basic science discoveries that claim clinical relevance lead to approved drugs within a decade, partly because of flawed pre-clinical animal research. A number of recent initiatives seek to improve the quality of such studies, and an article published this week in PLOS Medicine identifies key experimental procedures believed to increase clinical generalizability.

The authors, led by Jonathan Kimmelman of McGill University in Montréal, did a systematic literature search and identified 26 guidelines with 55 different procedures that groups of scientists had proposed to improve the quality and usefulness of preclinical efficacy studies. They then summarized and prioritized the results.

The key recommendations are listed in the new STREAM (Studies of TRanslation, Ethics And Medicine) checklist, and include performance of a power calculation to determine sample size, randomized treatment allocation, and in-depth characterization of disease phenotype in the prior to experimentation.

Preclinical is a critical step in drug development. More rigorous attention to experimental procedures protects patients in subsequent clinical trials and redeems the use of animals. It also promises to reduce the cost and delay in developing drugs.

The researchers suggest that: "Investigators, institutional review boards, journals, and funding agencies should give our prioritized recommendations due consideration when designing, evaluating, and sponsoring translational investigations."

More information: PLoS Med 10(7): e1001489. doi:10.1371/journal.pmed.1001489

add to favorites email to friend print save as pdf

Related Stories

Workshop calls for more detailed reporting in animal studies

Oct 10, 2012

A workshop sponsored by NIH's National Institute of Neurological Disorders and Stroke (NINDS) has produced a set of consensus recommendations to improve the design and reporting of animal studies. By making animal studies ...

Improving risk/benefit estimates in new drug trials

Mar 08, 2011

It's all too familiar: researchers announce the discovery of a new drug that eradicates disease in animals. Then, a few years later, the drug bombs in human trials. In the latest issue of the journal PLoS Medicine, ethics ...

Bias pervades the scientific reporting of animal studies

Jul 17, 2013

A new study published in the open access journal PLOS Biology suggests that the scientific literature could be compromised by substantial bias in the reporting of animal studies, and may be giving a misleading picture of the ...

Recommended for you

New MCAT shifts focus, will include humanities

Oct 20, 2014

(HealthDay)—The Medical College Admission Test (MCAT) has been revised, and the latest changes, including more humanities such as social sciences, are due to be implemented next April, according to a report ...

Using feminist theory to understand male rape

Oct 20, 2014

Decades of feminist research have framed rape and sexual assault as a 'women's issue', leaving little room for the experiences of male victims. But a new study published in the Journal of Gender Studies suggests that feminist ...

User comments